Skip to main content
. 2023 Jan 11;16(2):153–164. doi: 10.1007/s40271-022-00614-7

Table 1.

Attributes and levels included in the discrete choice experiment questions

Attribute Attribute description Attribute levels
Effectiveness Percentage reduction of the number of painful inflammatory lesions on your skin

25%

50%

75%

100%

Pain reduction Reduction of pain (on a scale ranging from 0 to 10)

Small pain relief (1 point)

Moderate pain relief (3 points)

Almost complete pain relief (6 points)

Duration of treatment benefit The duration in which the treatment provides the proposed effectiveness and pain relief

6 months

12 months

24 months

Risk of mild side effect Annual risk of experiencing a mild side effect while taking the treatment

100 people out of 1000 (10%)

300 people out of 1000 (30%)

500 people out of 1000 (50%)

Risk of serious infection Annual risk of experiencing a serious infection while taking the treatment

1 person out of 1000 (0.1%)

10 people out of 1000 (1%)

30 people out of 1000 (3%)

Mode of administration How the treatment is provided to you

Oral tablet, once every day

Subcutaneous injection, once every 2 weeks at home or in a clinic

Intravenous injection, once every 4 weeks in a clinic or hospital setting